Get all premium features to the best stock analysis tool

Finranks

Finranks

Company

  • About us

Contact us

  • [email protected]

Follow us

  • Instagram
  • Telegram
  • LinkedIn

All rights reserved.

Privacy PolicyTerms of Conditions
  • Home
  • Markets
  • Screener
  • News
  • About
  1. Home
  2. INDV
I

Indivior PLC (INDV)

NMS – Real Time Price. Currency in USD

28.97

-0.98 (-3.27%)

At close: Mar 27, 2026, 4:00 PM EDT

28.98

+0.01 (0.03%)

After-hours: Mar 27, 2026, 7:52 PM EDT

  • Summary
  • News
  • Chart
  • Financial
  • Dividends
  • Forecast
  • Ownership
  • Profile

Stock details

Previous close
28.97$
Day's range
28.9 - 30.1$
52-week range
8.64 - 38$
Volume
1 438 609
Average volume
3 620 510
Beta
0.77
EPS (TTM)
1.68
PE ratio (TTM)
17.45
Market cap
3 623 139 887
Shares outstanding
125 065 236
Dividend yield
N/A
Next earnings date
2026-04-23
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

About the company

Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a b... read more
CEO
Joseph Ciaffoni
Country
United States
IPO Date
Employees
1000
Fiscal Year End
January - December
Website
https://www.indivior.com

Revenue Breakdown

No Data

Revenue breakdown data has not been calculated yet.

News

No Data

There are no news for this stock.

Chart: INDV

Loading Chart...

Overall Score

4.7 / 1047%
Financial Strength
5.2
Profitability
8.2
Effectiveness
6.8
Growth
7.2
Forecast
5.9
Valuation
2.7

Financial Strength

NAMERATIOINDUSTRY5Y TRENDSCORE
Current ratio0.712.524.0
Quick ratio0.551.784.0
Debt to EquityN/A-0.801.0
Debt to Assets0.290.737.0
Interest coverage17.43-13.9010
Weighted average score5.2

Debt to Assets

Financial

Values in USD
(B=Billions, M=Millions, K=Thousands)
Values in USD (B=Billions, M=Millions, K=Thousands)
METRIC2022202320242025TTM
Total Revenue901M1.09B1.19B1.24B1.24B
Gross Profit729M919M977M1.02B1.02B
Operating Income209M234M270M358M360M
Net Income-53M-129M7M210M209M
EBITDA230M249M298M378M378M

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

NAMERATIOINDUSTRY5Y TRENDSCORE
Gross margin %82.1249.73
10
Operating margin %34.080.39
10
Net margin %28.49-50.32
10
EBITDA margin %35.47-16.02
10
Cash flow margin %-63.23124.71
1.0
Weighted average score8.2

Net Margin

Effectiveness

NAMERATIOINDUSTRY5Y TRENDSCORE
ROA7.19-42.45
7.0
ROEN/A-63.95
1.0
ROIC91.61-2.18
10
ROCE25.0842.71
9.0
Weighted average score6.8

Estimated EPS vs Actual EPS

Forecast

NAMEREVENUE GROWTHEPS GROWTHSCORE
Current quarter2.559.516.5
Next quarter-6.1246.275.5
Current year-6.4124.865.5
Next year5.2910.256.0
Weighted average score5.9

Analyst Rating

Growth

NAMEREVENUENET INCOMEEPSFCFSCORE
Q/Q14.01142.8613.89-301.426.8
Y/Y20.13385.71156.25-664.27.8
3y average11.43954.0130.56-1549.497.0
5y average14.09594.9449.11-894.777.3
Weighted average score7.2

Revenue Growth Rate vs. Industry

Valuation

NAMERATIOINDUSTRY5Q TRENDSCORE
P/E17.8813.57
4.8
PEG (5yr expected)N/A0.41
1.0
P/S3.03-0.30
4.0
P/B145.256.01
1.0
Weighted average score2.7

DCF Model

DCF Model PeriodN/A
Discount rateN/A
Perpetual growth rateN/A
Revenue 5 year CAGRN/A
FCF 5 year CAGRN/A
Fair value$
Stock price28.97$

Dividend

NAMECURRENTINDUSTRYSCORE
Dividend yield0.00N/A1.0
Payout ratio0.00N/A1.0
5-year dividend growth rateN/AN/A1.0
Years of dividend increaseN/AN/A1.0
Weighted average score1.0

Fair Value

Fair Value

$1

UndervaluedStock priceOvervalued

$28.97

Economic Moat

NAMESCALESCORE
Market shareNone1.0
Intangible assetsNone1.0
Switching costsNone1.0
Network effectNone1.0
Economies of scaleNone1.0
Weighted average score1.0
Dividend
1
Economic Moat
1

Octagon View

Strength & Weakness

Total debt $351.0M significantly exceeds cash reserves ($195.0M), raising financial stability concerns

Total current liabilities $914.0M surpass Total current assets $652.0M, signaling liquidity issues

Debt-to-equity ratio (-3.6) is well below the industry average (-0.8), showcasing prudent financial management

Interest coverage ratio (17x) indicates the company easily manages its debt payments

Negative free cash flow -$249.9M limits the company's ability to reinvest or pay down debt